PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30296051-0	2019	4,6-Diphenylpyrimidine Derivatives as Dual Inhibitors of Monoamine Oxidase and Acetylcholinesterase for the Treatment of Alzheimer"s Disease.	4,6-diphenylpyrimidine	0-22	acetylcholinesterase (Cartwright blood group)	Homo sapiens	57-99	
30296051-3	2019	A total of 15 new propargyl containing 4,6-diphenylpyrimidine derivatives were synthesized and screened for the MAO and AChE inhibition activities along with ROS production inhibition and metal-chelation potential.	4,6-diphenylpyrimidine	39-61	acetylcholinesterase (Cartwright blood group)	Homo sapiens	120-124	
30296051-13	2019	Thus, 4,6-diphenylpyrimidine derivatives can act as promising leads in the development of dual-acting inhibitors targeting MAO-A and AChE enzymes for the treatment of Alzheimer"s disease.	4,6-diphenylpyrimidine	6-28	acetylcholinesterase (Cartwright blood group)	Homo sapiens	133-137